Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
Titel:
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
Auteur:
Quinn, Colin H. Beierle, Andee M. Williams, Adele P. Marayati, Raoud Bownes, Laura V. Markert, Hooper R. Aye, Jamie M. Stewart, Jerry E. Mroczek-Musulman, Elizabeth Crossman, David K. Yoon, Karina J. Beierle, Elizabeth A.